© 2011 Biocia Inc.
All rights reserved |
 |
 |

| products ... |
Biocia has created a line of viscoadaptive eye drops for therapeutic and surgical indications which comply with regulatory guidelines in North America and Europe. These Products are being commercialized on a country-by-country basis in global markets based on current, pending and future licensing agreements with strategic partners. Biocia seeks leading small, mid-sized and larger companies as licensing partners for specific global markets and we welcome the opportunity to open a dialog with you..
The most important Biocia products currently developed include: I-Drop®, I-Drop® PM, I-Drop® Vet, I-Drop® Vet PLUS, I-Drop Multidose, Oasis Tears®, Oasis Tears® PLUS and Oasis Tears® Multidose which offer superior symptomatic relief of mild, moderate and very severe dry eye conditions without the use of harmful preservatives such as BAK.
The unique features of these Products include optimal elasticity and pseudoplasticity for comfort and long residence time in addition to mucoadhesive properties and blink-activated coating characteristics which provide lubrication and protection of vital ocular surfaces for long-lasting comfort and alleviation of chronic symptoms.
Biocia has a pipeline of future eye drop products in different stages of product development to complement these products now on the market.
A line of nasal Products are in different stages of commercialization and development for the treatment of dry nasal passages, enhancement of mucociliary transport clearance and clinical problems often associated with colds, influenza, dry air, bleeding, allergies, dust, smoke, air pollution, air conditioning, winter heating, high altitudes, travel, oxygen therapy, iatrogenic dry nose and nasal / sinus surgery. These Biocia brands include NasoVisc®, viscoprotective nasal solution and NasoVisc® Gel, viscoelastic mucus replacement for dry nose.
Please contact us for more information or visit our website at www.NasoViscGel.com. |
|
 |

|
|